Table 2. Characteristics of L-CE, L-Der p 1, L- Der p 2, and L-Com vaccines and placebo (L-PBS).
Parameter | Vaccine formulation | Placebo (L-PBS) |
|||
---|---|---|---|---|---|
L-CE | L-nDer p 1 | L- nDer p 2 | L-Com | ||
Average size (μm) (Mean ± SD) |
4.566 ± 0.023a | 1.999 ± 0.034b | 2.016 ± 0.120b | 1.025 ± 0.002c | 1.93 ± 0.02b |
Polydispersity (Mean ± SD) |
0.311 ± 0.078a | 0.799 ± 0.071b | 0.788 ± 0.070 b | 0.536 ± 0.020c | 1.00 ± 0.00d |
Zeta potential (Mean ± SD) |
31.33±0.58a | 35.40 ± 0.794a | 33.60 ± 1.058a | 35.00 ± 0.00a | 34.3 ± 2.15a |
% Entrapment | 81.64 | 88.03 | 90.56 | 88.34 | NA |
NA, not applicable
Entries with different superscripts (a, b, c and d) of the same horizontal line are statistically different (p <0.05)
Percent entrapment was calculated from one aliquot of each vaccine